Corgenix, Inc. Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	22
ISBN Number	not applicable
Product Code	GMD04749

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Corgenix, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1.1 List Of Tables
1.2 List of Figures
2 Company Overview
2.1 Key Information
2.2 Industry Outlook In Vitro Diagnostics
3 Major Products and Services
3.1 Overview
4 Key Employees
5 Locations And Subsidiaries
5.1 Head Office
5.2 Other Locations & Subsidiaries
6 Recent Developments
6.1 Product News
- 6.1.1 Jul 28, 2008: Corgenix Announces Collaboration With SpectraCell Laboratories
- 6.1.2 Apr 10, 2008: Corgenix Announces FDA Clearance For IgG Anti-AtherOx Test Kit
- 6.1.3 Apr 03, 2008: Corgenix Medical Corporation Signs Collaboration Agreement With Randox Laboratories To Develop And Market Automated Version Of AspirinWorks Test
- 6.1.4 Mar 18, 2008: Corgenix Acquires Rights To Serum Amyloid Technology
- 6.1.5 Feb 25, 2008: Corgenix Announces Issuance Of European Patent For Aspirin Resistance Testing
- 6.1.6 Oct 15, 2007: Corgenix Announces Initial Results In Development Of New Tests For Viral Infections And Bioterrorism Threats
- 6.1.7 Jul 30, 2007: Corgenix Submits 510(k) Filing For IgG Anti-AtherOx Test Kit
6.2 Product Approvals
- 6.2.1 Apr 10, 2008: Corgenix Announces FDA Clearance For IgG Anti-AtherOx Test Kit
6.3 Clinical Trials
- 6.3.1 Oct 15, 2007: Corgenix Announces Initial Results In Development Of New Tests For Viral Infections And Bioterrorism Threats
7 Corgenix, Inc. Pipeline Products
7.1 Corgenix, Inc. Product Pipeline Analysis
- 7.1.1 Corgenix, Inc. Pipeline Products By Equipment Type
- 7.1.2 Corgenix, Inc. Pipeline Products By Development Stage
- 7.1.3 Corgenix, Inc. Pipeline Products By Therapy Area
- 7.1.4 Corgenix, Inc. Pipeline Products By News Summary
7.2 VHF detection test
- 7.2.1 Product Description
- 7.2.2 Product Status
- 7.2.3 Product Milestone
7.3 Serum Amyloid Technology
- 7.3.1 Product Description
- 7.3.2 Product Status
- 7.3.3 Product Milestone
7.4 Automated Version of AspirinWorks Test
- 7.4.1 Product Description
- 7.4.2 Product Status
- 7.4.3 Product Milestone
8 Appendix
8.1 Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Expert Panel Validation
8.2 Contact Us
8.3 About Global Markets Direct
8.4 Disclaimer
1 List of Tables
Table 1: Corgenix, Inc.,Key Facts
Table 2: Corgenix, Inc., Key Employees,
Table 3: Corgenix, Inc., Other Locations
Table 4: Corgenix, Inc. Pipeline Products by Equipment Type
Table 5: Corgenix, Inc. Pipeline Products By Development Stage
Table 6: Corgenix, Inc. Pipeline Products By Therapy Area
Table 7: Corgenix, Inc. Pipeline Products By News Summaries
1.2 List of Figures
Figure 1: Corgenix, Inc. Pipeline Products By Development Stage
Figure 2: Global Markets Direct Methodology